Global Meningococcal Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Type (Polysaccharide Vaccines, Conjugate Vaccines, Combination Vaccines, and Others), By Brand Name ( Menactra, Menveo, Nimenrix, Trumenba, Bexsero, and Others), By End-user (Hospitals, Pharmacy Stores, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa), Analysis and Forecast 2021 – 2030.

Industry: Healthcare
RELEASE DATE Nov 2022
REPORT ID SI1290
PAGES 208
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis By Type
      2. Market Attractiveness Analysis By Brand Name
      3. Market Attractiveness Analysis By End User
      4. Market Attractiveness Analysis By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rise in incidence of infectious disease
    3. Restraints
      1. Side effects
    4. Opportunities
      1. Rise in R&D
    5. Challenge
      1. Lack of awareness
  6. Global Meningococcal Vaccines Market Analysis and Projection, By Type
    1. Segment Overview
    2. Polysaccharide Vaccines
    3. Conjugate Vaccines
    4. Combination Vaccines
    5.  Others
  7. Global Meningococcal Vaccines Market Analysis and Projection, By Brand Name
    1.  Segment Overview
    2. Menactra
    3. Menveo
    4.  Nimenrix
    5. Trumenba
    6.  Bexsero
    7. Others
  8. Global Meningococcal Vaccines Market Analysis and Projection, By End User
    1.  Segment Overview
    2.  Hospitals
    3. Pharmacy Stores
    4. Others
  9. Global Meningococcal Vaccines Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  10. Global Meningococcal Vaccines Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Meningococcal Vaccines Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  11. Company Profiles
    1.   Bio-Manguinhos
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
    2. SWOT Analysis
  12.    Biomed Pvt. Ltd
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  13.  GlaxoSmithKline plc
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  14.  Merck & Co., Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  15. Novartis AG
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  16.    Pfizer Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  17.  Sanofi Pasteur Inc.
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis
  18.    Serum Institute of India Ltd
    1. Business Overview
    2. Company Snapshot
    3. Company Market Share Analysis
    4. Company Coverage Portfolio
    5. Recent Developments
    6. SWOT Analysis

List of Table

  1. Global Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  2. Global Polysaccharide Vaccines, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  3. Global Conjugate Vaccines, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  4. Global Combination Vaccines, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  5. Global Others, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  6. Global Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion) 
  7. Global Menactra, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  8. Global Menveo, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  9. Global Nimenrix, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  10. Global Trumenba, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  11. Global Bexsero, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  12.  Global Others, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  13. Global Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  14. Global Hospitals, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  15. Global Pharmacy Stores, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  16. Global Others, Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  17. Global Meningococcal Vaccines Market, By Region, 2022-2030(USD Billion)
  18. North America Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  19. North America Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  20. North America Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  21. U.S. Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  22. U.S. Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  23. U.S. Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  24. Canada Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  25. Canada Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  26. Canada Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  27. Mexico Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  28. Mexico Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  29. Mexico Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  30. Europe Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  31. Europe Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  32. Europe Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  33. Germany Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  34. Germany Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  35. Germany Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  36. France Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  37. France Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  38. France Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  39. U.K. Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  40. U.K. Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  41. U.K. Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  42. Italy Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  43. Italy Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  44. Italy Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  45. Spain Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  46. Spain Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  47. Spain Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  48. Asia Pacific Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  49. Asia Pacific Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  50. Asia Pacific Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  51. Japan Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  52. Japan Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  53. Japan Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  54. China Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  55. China Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  56. China Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  57. India Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  58. India Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  59. India Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  60. South America Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  61. South America Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  62. South America Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion) 
  63. Brazil Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  64. Brazil Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  65. Brazil Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  66. The Middle East and Africa Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  67. The Middle East and Africa Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  68. The Middle East and Africa Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  69. UAE Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  70. UAE Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  71. UAE Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)
  72. South Africa Meningococcal Vaccines Market, By Type, 2022-2030(USD Billion)
  73. South Africa Meningococcal Vaccines Market, By Brand Name, 2022-2030(USD Billion)
  74. South Africa Meningococcal Vaccines Market, By End User, 2022-2030(USD Billion)

 

List of Figures 

  1. Global Meningococcal Vaccines Market Segmentation
  2. Meningococcal Vaccines Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Meningococcal Vaccines Market
  9. Top Winning Strategies, 2022-2030
  10. Top Winning Strategies, By Development, 2022-2030(%)
  11. Top Winning Strategies, By Company, 2022-2030
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers: Meningococcal Vaccines Market
  20. Meningococcal Vaccines Market Segmentation, By Type
  21. Meningococcal Vaccines Market For Polysaccharide Vaccines, By Region, 2022-2030 ($Billion)
  22. Meningococcal Vaccines Market For Conjugate Vaccines, By Region, 2022-2030 ($Billion)
  23. Meningococcal Vaccines Market For Combination Vaccines, By Region, 2022-2030 ($Billion)
  24. Meningococcal Vaccines Market For Others, By Region, 2022-2030 ($Billion)
  25. Meningococcal Vaccines Market Segmentation, By Brand Name
  26. Meningococcal Vaccines Market For Menactra, By Region, 2022-2030 ($Billion)
  27. Meningococcal Vaccines Market For Menveo, By Region, 2022-2030 ($Billion)
  28. Meningococcal Vaccines Market For Nimenrix, By Region, 2022-2030 ($Billion)
  29. Meningococcal Vaccines Market For Trumenba, By Region, 2022-2030 ($Billion)
  30. Meningococcal Vaccines Market For Bexsero, By Region, 2022-2030 ($Billion)
  31. Meningococcal Vaccines Market For Others, By Region, 2022-2030 ($Billion)
  32. Meningococcal Vaccines Market Segmentation, By End User
  33. Meningococcal Vaccines Market For Hospitals, By Region, 2022-2030 ($Billion)
  34. Meningococcal Vaccines Market For Pharmacy Stores, By Region, 2022-2030 ($Billion)
  35. Meningococcal Vaccines Market For Others, By Region, 2022-2030 ($Billion)
  36. Procter & Gamble: Net Sales, 2022-2030 ($Billion)
  37. Procter & Gamble: Revenue Share, By Segment, 2022 (%)
  38. Procter & Gamble: Revenue Share, By Region, 2022 (%)
  39. PHYTOMER: Net Sales, 2022-2030 ($Billion)
  40. PHYTOMER: Revenue Share, By Segment, 2022 (%)
  41. PHYTOMER: Revenue Share, By Region, 2022 (%)
  42. Deka Corporation: Net Sales, 2022-2030 ($Billion)
  43. Deka Corporation: Revenue Share, By Segment, 2022 (%)
  44. Deka Corporation: Revenue Share, By Region, 2022 (%)
  45. Johnson & Johnson: Net Sales, 2022-2030 ($Billion)
  46. Johnson & Johnson: Revenue Share, By Segment, 2022 (%)
  47. Johnson & Johnson: Revenue Share, By Region, 2022 (%)
  48. Unilever Plc.: Net Sales, 2022-2030 ($Billion)
  49. Unilever Plc.: Revenue Share, By Segment, 2022 (%)
  50. Unilever Plc.: Revenue Share, By Region, 2022 (%)
  51. Kao Corporation: Net Sales, 2022-2030 ($Billion)
  52. Kao Corporation: Revenue Share, By Segment, 2022 (%)
  53. Kao Corporation: Revenue Share, By Region, 2022 (%)
  54. ZO Skin Health, Inc.: Net Sales, 2022-2030 ($Billion)
  55. ZO Skin Health, Inc.: Revenue Share, By Segment, 2022 (%)
  56. ZO Skin Health, Inc.: Revenue Share, By Region, 2022 (%)
  57. L’Oreal Paris: Net Sales, 2022-2030 ($Billion)
  58. L’Oreal Paris: Revenue Share, By Segment, 2022 (%)
  59. L’Oreal Paris: Revenue Share, By Region, 2022 (%)
  60. Shiseido Company Limited: Net Sales, 2022-2030 ($Billion)
  61. Shiseido Company Limited: Revenue Share, By Segment, 2022 (%)
  62. Shiseido Company Limited: Revenue Share, By Region, 2022 (%)
  63. Estee Lauder Companies, Inc.: Net Sales, 2022-2030 ($Billion)
  64. Estee Lauder Companies, Inc.: Revenue Share, By Segment, 2022 (%)
  65. Estee Lauder Companies, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2021
Tables & Figures:139
Pages:208
Countries covered:16
Companies covered::8
Forecast CAGR:6.5%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies